AU771099B2 - Inhibitors of the integrin alphavbeta6 - Google Patents

Inhibitors of the integrin alphavbeta6 Download PDF

Info

Publication number
AU771099B2
AU771099B2 AU62630/00A AU6263000A AU771099B2 AU 771099 B2 AU771099 B2 AU 771099B2 AU 62630/00 A AU62630/00 A AU 62630/00A AU 6263000 A AU6263000 A AU 6263000A AU 771099 B2 AU771099 B2 AU 771099B2
Authority
AU
Australia
Prior art keywords
leu
asp
arg
ser
thr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU62630/00A
Other languages
English (en)
Other versions
AU6263000A (en
Inventor
Beate Diefenbach
Ulrich Groth
Alfred Jonczyk
Gunther Zischinsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of AU6263000A publication Critical patent/AU6263000A/en
Application granted granted Critical
Publication of AU771099B2 publication Critical patent/AU771099B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU62630/00A 1999-06-26 2000-06-13 Inhibitors of the integrin alphavbeta6 Ceased AU771099B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19929410 1999-06-26
DE19929410A DE19929410A1 (de) 1999-06-26 1999-06-26 Inhibitoren des Integrins avß6
PCT/EP2000/005404 WO2001000660A1 (de) 1999-06-26 2000-06-13 INHIBITOREN DES INTEGRINS αv$(g)b¿6?

Publications (2)

Publication Number Publication Date
AU6263000A AU6263000A (en) 2001-01-31
AU771099B2 true AU771099B2 (en) 2004-03-11

Family

ID=7912712

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62630/00A Ceased AU771099B2 (en) 1999-06-26 2000-06-13 Inhibitors of the integrin alphavbeta6

Country Status (17)

Country Link
EP (1) EP1189930A1 (cs)
JP (1) JP2003503422A (cs)
KR (1) KR20020015704A (cs)
CN (1) CN1358195A (cs)
AR (1) AR024472A1 (cs)
AU (1) AU771099B2 (cs)
BR (1) BR0011954A (cs)
CA (1) CA2377224A1 (cs)
CZ (1) CZ20014484A3 (cs)
DE (1) DE19929410A1 (cs)
HU (1) HUP0201729A3 (cs)
MX (1) MXPA01013247A (cs)
NO (1) NO20016341L (cs)
PL (1) PL352374A1 (cs)
SK (1) SK18722001A3 (cs)
WO (1) WO2001000660A1 (cs)
ZA (1) ZA200200673B (cs)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004208865B2 (en) * 2003-02-06 2010-06-17 Merck Patent Gmbh Peptidic sulfonamides

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6972296B2 (en) 1999-05-07 2005-12-06 Encysive Pharmaceuticals Inc. Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
GB0520068D0 (en) * 2005-10-03 2005-11-09 Cancer Res Technology av peptide ligand
RU2009107277A (ru) 2006-08-03 2010-09-10 Астразенека Аб (Se) АНТИТЕЛА, НАЦЕЛЕННЫЕ НА αVβ6, И ИХ ПРИМЕНЕНИЕ
EA201991102A1 (ru) * 2016-11-01 2019-09-30 Эрроухед Фармасьютикалс, Инк. Альфа-v бета-6 лиганды интегрина и варианты их применения
UA128250C2 (uk) 2017-11-01 2024-05-22 Ерроухед Фармасьютикалс, Інк. Ліганди інтегринів і їх застосування

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06511477A (ja) * 1991-05-14 1994-12-22 ボード　オブ　リージェンツ　オブ　ザ　ユニバーシティ　オブ　オクラホマ 炎症のペプチド阻害剤
ES2235350T3 (es) * 1997-08-08 2005-07-01 The Regents Of The University Of California Tratamiento de la fibrosis renal con anticuerpos contra la integrina alfa-v-beta 6.
BR9916323A (pt) * 1998-12-19 2001-10-30 Merck Patent Gmbh Inibidores da integrina alfavbeta6

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004208865B2 (en) * 2003-02-06 2010-06-17 Merck Patent Gmbh Peptidic sulfonamides

Also Published As

Publication number Publication date
KR20020015704A (ko) 2002-02-28
CZ20014484A3 (cs) 2002-04-17
JP2003503422A (ja) 2003-01-28
NO20016341D0 (no) 2001-12-21
NO20016341L (no) 2002-02-25
PL352374A1 (en) 2003-08-25
BR0011954A (pt) 2002-05-07
CA2377224A1 (en) 2001-01-04
EP1189930A1 (de) 2002-03-27
WO2001000660A1 (de) 2001-01-04
HUP0201729A3 (en) 2005-01-28
HUP0201729A2 (en) 2002-08-28
ZA200200673B (en) 2003-04-24
DE19929410A1 (de) 2000-12-28
MXPA01013247A (es) 2002-07-02
AR024472A1 (es) 2002-10-02
SK18722001A3 (sk) 2002-05-09
CN1358195A (zh) 2002-07-10
AU6263000A (en) 2001-01-31

Similar Documents

Publication Publication Date Title
AU717574B2 (en) Cyclic adhesion inhibitors
AU684489B2 (en) Linear adhesion inhibitors
AU772782B2 (en) Cyclic peptide derivatives as inhibitors of integrin alphavbeta6
US6127335A (en) Cyclic adhesion inhibitors
CA2355874A1 (en) .alpha.v.beta.6 integrin inhibitors
AU771099B2 (en) Inhibitors of the integrin alphavbeta6
CA2185394C (en) Biotinderivate
AU770295B2 (en) AlphaVbetaB integrin inhibitors
US7759302B2 (en) Peptidic sulfonamides
MXPA01006229A (en) &agr;v

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)